Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Dendritic Cell Vaccine for Malignant Melanoma
NCT00197912Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Sep 2004
- Primary completion
- Apr 2010
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of tumor antigen loaded autologous dendritic cells in melanoma, sponsored by Herlev Hospital. Started Sep 2004; status: completed.
02
Drugs
tumor antigen loaded autologous dendritic cells
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00197912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197912.